You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
(Start of Back Button)
destockquicktake
(End of Back Button)
Morningstar® Stock Report™
Biotest AG
BIOd
Portfolio hinzuf.
Drucken
Definitionen
PDF
Aktienkurs
Chart
Bilanzdaten
Kernkennzahlen
Dokumente
Nachrichten
Rentabilität
Wachstumsraten
Cash Flow
Finanzielle Stabilität
Effizienzkennzahlen
(Start of Section)
Gewinnmarge (% des Umsatzes)
2019
2020
2021
2022
2023
Ertrag
100,00%
100,00%
100,00%
100,00%
100,00%
Betriebskosten
69,27%
73,13%
84,35%
75,80%
59,06%
Bruttogewinn
30,73%
26,87%
15,65%
24,20%
40,94%
Vertriebsgemeinkosten
19,30%
16,19%
15,75%
15,64%
11,83%
Forschung und Entwicklung
12,74%
11,52%
10,14%
9,78%
9,76%
Umsatzrendite
-1,60%
-0,52%
-10,10%
-1,65%
17,54%
Net Int, Inc and Other
-1,91%
-6,71%
-22,25%
-7,61%
33,07%
EBIT Marge
-0,31%
-6,20%
-12,14%
-5,97%
15,53%
(End of Section)
(Start of Section)
Ertragskraft
2019
2020
2021
2022
2023
Steuersatz
0,81%
0,29%
0,14%
0,16%
-3,02%
Nettomarge
-1,12%
-6,48%
-12,30%
-6,14%
18,55%
Gesamtkapitalrendite
-0,47
-2,84
-5,71
-2,78
9,72
Financial Leverage
2,32
2,56
2,90
3,24
2,83
Eigenkapitalsrendite
-1,05
-6,92
-15,52
-8,54
29,20
(End of Section)